COCOS 4 Is Here, Fully Open Source
BEIJING, Jan. 5, 2026 /PRNewswire/ -- COCOS, the globally renowned provider of game engines and development tools fully acquired by SUD, today announced the full open-sourcing of COCOS 4. COCOS 4 Fully Open Source Scope of Open Source The following...
Timekettle Announces 2026 Breakthroughs in AI Interpretation, Introducing Its State-of-the-Art Translation Engine Selector and Next-Generation Bone-Conduction Voice Capture
Flagship W4 Earbuds Become the Most Accurate Interpreter Device Ever Released LAS VEGAS, Jan. 5, 2026 /PRNewswire/ -- Timekettle, the global leader in AI-powered cross-language communication, today announces a major system-wide upgrade that...
Meraas unveils Dubai Design District residential masterplan, introducing a world-class waterfront neighbourhood
DUBAI, UAE, Jan. 5, 2026 /PRNewswire/ -- Meraas, a member of Dubai Holding Real Estate, has unveiled an expanded residential masterplan for Dubai Design District (d3), transforming the district into one of Dubai's most desirable creative-led...
Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA
CHENGDU, China, Jan. 5, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that its Investigational New Drug (IND) application for SKB105 (also known as CR-003), an internally...
Bybit Launches Program to Upskill Sri Lankan Creators with Fully Sponsored Market Education Program
DUBAI, UAE, Jan. 5, 2026 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has launched a fully sponsored market literacy education initiative aimed at supporting financial literacy and responsible market...
Sisram Medical Reports Completion of NIFDC Testing for DAXXIFY in China
Marking a Key Milestone Toward Market Launch and Strengthening Sisram's Premium Aesthetics Portfolio HONG KONG, Jan. 5, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred...
Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC
CHENGDU, China, Jan. 5, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company," 6990.HK) today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, also...
JustMarkets Announces Boost Contest for All Clients
HO CHI MINH CITY, Vietnam, Jan. 5, 2026 /PRNewswire/ -- JustMarkets, a worldwide broker with more than 12 years of experience in the online trading realm, is launching the Boost Contest, which represents a large-scale trading activity with the...